Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,190.00
-60.00 (-1.85%)
Last updated: Oct 2, 2025, 9:00 AM KST

Prestige Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21 2016 - 2020
248,420283,797245,391272,542184,546453,181
Upgrade
Market Cap Growth
-30.36%15.65%-9.96%47.68%-59.28%-
Upgrade
Enterprise Value
338,299364,568378,645369,331283,846447,789
Upgrade
Last Close Price
3195.003650.003990.004460.003020.009600.00
Upgrade
PS Ratio
19.8222.64113.13156.1111855.95140.44
Upgrade
PB Ratio
1.842.103.422.731.574.24
Upgrade
P/TBV Ratio
1.852.123.462.761.584.31
Upgrade
EV/Sales Ratio
26.9929.09174.57211.5518235.34138.77
Upgrade
Debt / Equity Ratio
0.680.682.411.601.010.73
Upgrade
Asset Turnover
0.050.050.01-00.03
Upgrade
Inventory Turnover
1.281.280.89-0.000.14
Upgrade
Quick Ratio
0.060.060.340.530.541.59
Upgrade
Current Ratio
0.400.400.600.790.921.93
Upgrade
Return on Equity (ROE)
-26.55%-26.55%-34.26%--44.30%-74.70%
Upgrade
Return on Assets (ROA)
-7.52%-7.52%-7.02%--9.85%-13.05%
Upgrade
Return on Capital (ROIC)
-8.93%-8.93%-8.28%--10.87%-15.88%
Upgrade
Earnings Yield
-11.06%-9.68%-11.97%-14.47%-26.94%-8.69%
Upgrade
FCF Yield
-9.47%-8.29%-6.87%-22.11%-64.36%-27.17%
Upgrade
Buyback Yield / Dilution
-20.50%-20.50%-4.32%-13.35%-16.43%-25.46%
Upgrade
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.